Geoffrey Ling M.D. insider trades

Open-market stock purchases and sales by Geoffrey Ling M.D., Director at Celularity Inc, from SEC Form 4 filings since Jan 15, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +111%.

Recent trades

DateStockTradeValue
Jan 12, 2026CELU Celularity IncBought (not open market)—
Jan 12, 2026CELU Celularity IncBought (not open market)—
Dec 29, 2025CELU Celularity IncBought (not open market)—
Dec 29, 2025CELU Celularity IncBought (not open market)—
Dec 19, 2025CELU Celularity IncBought (not open market)—
Nov 19, 2025CELU Celularity IncBought (not open market)—

Companies traded

  • CELU Celularity Inc: other filings, last Jan 12, 2026
  • CBIO Catalyst Biosciences, Inc: 1 buy, last Jan 7, 2022

Get free alerts when Geoffrey Ling M.D. files a new trade →